BioCentury
ARTICLE | Clinical News

BM32: Phase IIb ongoing

December 23, 2013 8:00 AM UTC

Biomay said an independent DMC recommended continuation of a double-blind, placebo-controlled, European Phase IIb trial of BM32 into the next treatment year based on a review of symptom medication sco...